ArticleMolecular therapy oncolytics2022

Cancer stem/progenitor signatures refine the classification of clear cell renal cell carcinoma with stratified prognosis and decreased immunotherapy efficacy.

Peng Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.